Low-frequency neuromuscular depression is a consequence of a reduction in nerve terminal Ca2+ currents at mammalian motor nerve endings.
Low-frequency neuromuscular depression is a consequence of a reduction in nerve terminal Ca2+ currents at mammalian motor nerve endings.
复制标题
低频神经肌肉抑制是哺乳动物运动神经末梢神经末梢 Ca2 电流减少的结果。
DOI:
10.1097/aln.0b013e31829083d8
复制
发表时间:
2013
期刊:
影响因子:
8.8
通讯作者:
Silinsky,EugeneM
中科院分区:
文献类型:
--
作者:
Silinsky,EugeneM
BackgroundThe decline in voluntary muscle contraction during low-frequency nerve stimulation is used clinically to assess the type and degree of neuromuscular block. The mechanism underlying this depression is unknown.MethodsSimultaneous electrophysiological measurements of neurotransmitter release and prejunctional Ca2+ currents were made at mouse neuromuscular junctions to evaluate the hypothesis that decreases in nerve terminal Ca2+ currents are responsible for low-frequency depression.ResultsUnder conditions generally used to measure Ca2+ currents at the neuromuscular junction, increasing the frequency of nerve stimulation briefly from 0.017 to 0.1–1 Hz caused a simultaneous reduction in the release of the neurotransmitter acetylcholine to 52.2±4.4% of control and the Ca2+ current peak to 75.4±2.0% of control (P< 0.001, n= 5 experiments for both measurements, mean±SEM for all data). In conditions used for train-of-four monitoring (4 stimuli, 2 Hz), neurotransmitter release declined to 42.0±1.0% of control and the Ca2+ current peak declined to 75.8±3.3% of control between the first and fourth stimulus (P< 0.001, n= 7 experiments for both measurements). Depression in acetylcholine release during train-of-four protocols also occurred in the absence of neuromuscular-blocking drugs.DiscussionThe results demonstrate that neuromuscular depression during train-of-four monitoring is due to a decline in nerve terminal Ca2+ currents, hence reducing the release of acetylcholine. As similar processes may come into play at higher stimulation frequencies, agents that antagonize the decline in Ca2+ currents could be used to treat conditions in which neuromuscular depression can be debilitating.